Back to Search
MONICA FORNIER, MD
MD
Medical Oncology Physician
NPI: 1720059751IndividualAccepts Medicare
Education
OTHER
Class of 1992
Research & Publications (20)
Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues.
PMID 18021476·Clin Breast Cancer·2007
6-review
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.
PMID 17200358·Clin Cancer Res·2007
3-trial
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.
PMID 17908977·Clin Cancer Res·2007
3-trial
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
PMID 16134178·Cancer·2005
8-other
Dose-dense adjuvant chemotherapy for primary breast cancer.
PMID 15743513·Breast Cancer Res·2005
8-other
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate.
PMID 15668276·Ann Oncol·2005
8-other
HER2 testing and correlation with efficacy of trastuzumab therapy.
PMID 12435204·Oncology (Williston Park)·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 205 E 64TH ST
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1720059751
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile